Proteomic Biomarkers
Proteomics biomarkers refer to proteins in biological samples, such as blood, urine, or tissues, whose expression levels change due to alterations in disease or physiological conditions.
I. Main Applications
1. Disease Diagnosis:
Specific proteomics biomarkers can assist doctors in diagnosing certain diseases, especially in the early stages when other symptoms and signs are not evident.
2. Monitoring Treatment Effectiveness:
By tracking changes in biomarkers, doctors can evaluate the effectiveness of treatment plans and adjust treatment strategies promptly.
3. Disease Prognosis Evaluation:
The expression levels of certain proteomics biomarkers are closely related to the severity and prognosis of a disease and can be used to predict disease progression trends.
4. Drug Development:
Proteomics biomarkers can serve as targets for drug development, assisting scientists in designing therapies that target specific molecular mechanisms.
II. Techniques and Methods
1. Mass Spectrometry:
Mass spectrometry is one of the most commonly used techniques in proteomics research, used for identifying and quantifying proteins in complex biological samples.
2. Two-Dimensional Electrophoresis:
Through two-dimensional electrophoresis, proteins in complex samples can be separated, followed by mass spectrometry analysis for identification and quantification.
3. Immunoassay Techniques:
Techniques like Enzyme-Linked Immunosorbent Assay (ELISA) and Western Blot are used for the detection and quantification of specific proteins.
4. Bioinformatics:
Bioinformatics tools are used to analyze and interpret large-scale proteomics data, helping to identify potential disease biomarkers.
BiotechPack, A Biopharmaceutical Characterization and Multi-Omics Mass Spectrometry (MS) Services Provider
Related Services:
Proteomics Bioinformatics Analysis
Proteomics Data Quality Assessment
Proteomics Analysis Strategies
Detection of Protein Expression Levels in Proteomics
Quantitative Proteomics Analysis
How to order?
